SANTA ROSA, Calif., Sept. 22 /PRNewswire/ -- Osseon Therapeutics, Inc., a Santa Rosa, California, manufacturer of spinal medical devices for the minimally invasive treatment of spinal compression fractures, today announced it has signed a five-year agreement with MBA Incorporado, SL to distribute Osseon’s suite of products in the European and South American markets. MBA is a leading medical device marketing and distribution organization and specializes in the sale of products used for treatment of the spine. MBA is the largest private independent distributor of orthopaedic devices in Europe, generating more than $100 million in total sales in 2008.
Osseoflex is a steerable and curvable needle that can access the majority of the vertebral body from a single percutaneous access point. The Osseoperm system is customized for delivering optimal viscosity cement and precise cement placement through the Osseoflex needle. The Osseoplasty procedure provides rapid stabilization of vertebral fractures and significant pain relief in most patients within the same day.
“Osseon is excited to partner with MBA, the leading distributor of biomedical spine treatment products in Europe and South America,” said Dr. John Stalcup, CEO of Osseon Therapeutics. “MBA is known as the ‘state-of-the-science’ innovator in these markets for medical devices, always at the forefront of distribution and support of advanced medical technologies. Having MBA as our exclusive distributor will bring immediate and long-lasting relationships with the leading physicians and hospitals treating spinal compression fractures. We are, indeed, pleased to have MBA as our sole representative.”
“MBA has an excellent and long-established international reputation for marketing and distributing medical devices for independent innovators and an unparalleled reputation for customer service. The Agreement today between MBA and Osseon represents a major step forward in the expansion of these services into the key markets of Europe and Latin America.”
To learn more about Osseon, please visit our website: http://www.osseon.com/
SOURCE Osseon Therapeutics, Inc.
CONTACT: Michael Bivens, Marketing Director of Osseon Therapeutics, Inc.,
+1-503-475-3333, michael.bivens@osseon.com
Web site: http://www.osseon.com/
